title: Who should conduct modeling and cost-effectiveness analysis?
authors: Swedish Council on Health Technology Assessment (SBU) Karolinska Institutet, Department of Learning, Informatics, Management and Ethics.
authors: Måns
authors: M
authors: Rosén
mesh_terms: D003362:Cost-Benefit Analysis; D003657:Decision Making; D004363:Drug Utilization / Q000191:economics*; D006801:Humans; D018803:Models, Economic; D055553:Prescription Drugs / Q000191:economics*; D013673:Technology Assessment, Biomedical
chemical_list: D055553:Prescription Drugs